Greenway Health Prior Authorization for Psychiatry

Klivira streamlines Greenway Health prior authorization for psychiatry, integrating directly with your ambulatory EHR to automate complex behavioral health PA workflows.

For ambulatory practices leveraging Greenway Health's Intergy or Prime Suite, managing prior authorizations for psychiatric services presents unique challenges. Behavioral health PA often involves intricate level-of-care criteria, step therapy for specialty medications, and continuous concurrent reviews. Klivira provides a robust solution to navigate these complexities, enhancing operational efficiency and reducing administrative burden for your psychiatry teams.

The Intersection of Greenway Health and Psychiatric PA Workflows

Greenway Health's ambulatory EHR portfolio, including Intergy and Prime Suite, serves a wide range of specialty practices. For psychiatry, the platform manages patient demographics, scheduling, and clinical documentation. Integrating prior authorization directly within this existing workflow is critical to avoid context switching and manual data entry. Klivira's integration via the Greenway Marketplace allows for a seamless experience, initiating PA requests from within the patient chart.

High-Volume Prior Authorization Categories in Psychiatry

Psychiatric services frequently trigger prior authorizations due to the high cost and specificity of certain treatments and medications. These often include atypical antipsychotics, ADHD stimulants (controlled substances), transcranial magnetic stimulation (TMS), and esketamine/ketamine treatments. Additionally, higher levels of care such as inpatient psychiatric admissions, partial hospitalization (PHP), intensive outpatient (IOP), and residential treatment are heavily managed, requiring detailed clinical justification.

Key Documentation Requirements for Psychiatric PAs

**Level of Care Justification:** DSM-5-TR diagnosis, severity scales (e.g., PHQ-9, GAD-7, Beck scales), safety risk assessments for inpatient/residential admissions.
**ASAM Criteria:** For substance use disorder admissions, documentation across the six ASAM dimensions is frequently required.
**Medication Trials:** For TMS and ECT, documentation of failed antidepressant trials (often 2-4 with adequate dose/duration) is standard.
**Specialty Drug Protocols:** Diagnosis confirmation, prior oral medication trials, and specific REMS documentation for drugs like esketamine (Spravato) or brexanolone (Zulresso).

Klivira's Approach to Psychiatry PA Automation within Greenway

Klivira's platform is engineered to address the specific demands of psychiatric prior authorization. Our system leverages ASAM-criteria-aware logic for level-of-care determinations, automates the collection of necessary documentation for step-therapy requirements (e.g., failed antidepressant trials for TMS), and manages continuous concurrent review workflows for extended stays. By integrating with Greenway Health, Klivira ensures that these complex requirements are met efficiently, reducing denials and accelerating access to care.

Addressing Common Denial Reasons and Workflow Constraints

Psychiatry practices often face denials due to ASAM level mismatches, insufficient step-therapy documentation, or concurrent review denials when severity criteria are no longer met. Workflow constraints include time-sensitive admission decisions for emergencies and the continuous nature of concurrent reviews. Klivira mitigates these issues by providing a structured workflow that flags potential parity-act violations and supports expedited authorization processes, ensuring compliance and timely patient care.

Frequently asked questions

How does Klivira integrate with Greenway Health for psychiatry prior authorizations?

Klivira integrates with Greenway Health, including Intergy and Prime Suite, via the Greenway Marketplace. This allows for the initiation of prior authorization requests directly from the patient's chart within the EMR, streamlining the process and minimizing redundant data entry for psychiatry teams.

What specific psychiatric treatments does Klivira help authorize?

Klivira supports prior authorizations for a wide range of psychiatric treatments, including specialty medications like atypical antipsychotics and long-acting injectables, ADHD stimulants, TMS, ECT, esketamine/ketamine, and various levels of care such as inpatient, PHP, IOP, and residential treatment.

Does Klivira assist with ASAM criteria for SUD prior authorizations?

Yes, Klivira's platform incorporates ASAM-criteria-aware level-of-care logic. This helps ensure that prior authorization requests for substance use disorder (SUD) admissions and continued stays are accurately documented across the six ASAM dimensions, aligning with payer requirements.

Can Klivira help with step therapy documentation for TMS or specialty medications?

Absolutely. Klivira automates the collection and submission of documentation required for step therapy, such as detailed records of failed antidepressant trials for TMS, or prior oral medication trials for specialty injectables. This reduces the administrative burden and improves authorization success rates.

How does Klivira address time-sensitive psychiatric PA requests?

Klivira's workflow is designed to support expedited authorization processes critical for time-sensitive psychiatric and SUD admissions. The platform streamlines documentation and submission, helping clinics obtain necessary approvals quickly to facilitate timely patient access to care.